Connections between psoriasis and Crohn's disease
- PMID: 12789169
- DOI: 10.1067/mjd.2003.540
Connections between psoriasis and Crohn's disease
Abstract
The prevalence of psoriasis in patients with Crohn's disease (CD) is higher than chance would allow if they were mutually exclusive diseases. A close examination reveals genetic and pathologic connections between these diseases. An appreciation for the role of tumor necrosis factor-alpha in both diseases has proven very important. Increased levels of this inflammatory cytokine have been measured in CD lesions, and in 1997 a clinical trial demonstrated the response of this disease to infliximab, a monoclonal antibody specific for tumor necrosis factor-alpha. A subsequent clinical trial evaluated infliximab in a patient with CD and psoriasis, another disease in which increased levels of tumor necrosis factor-alpha are seen in lesions. Scientists noticed the marked skin improvement of this patient and later demonstrated the efficacy of infliximab for psoriasis in a randomized, double-blind, placebo-controlled trial. Thus, an appreciation for connections between psoriasis and CD can suggest novel therapeutic strategies with ensuing benefits to patients. This article reviews epidemiologic, genetic, and pathologic connections between psoriasis and CD and discusses pharmaceuticals targeting inflammatory mediators common to each disease. (J Am Acad Dermatol 2003;48:805-21.)
Learning objective: At the completion of this learning activity, participants should understand how psoriasis and Crohn's disease are related at epidemiologic, genetic, and pathological levels and should appreciate how to use this knowledge to treat these diseases.
Similar articles
-
Development of psoriasis scalp with alopecia during treatment of Crohn's disease with infliximab and rapid response to both diseases to ustekinumab.Eur Rev Med Pharmacol Sci. 2013 Oct;17(20):2831-6. Eur Rev Med Pharmacol Sci. 2013. PMID: 24174369
-
Gene polymorphisms that can predict response to anti-TNF therapy in patients with psoriasis and related autoimmune diseases.Pharmacogenomics J. 2013 Aug;13(4):297-305. doi: 10.1038/tpj.2012.53. Epub 2013 Jan 22. Pharmacogenomics J. 2013. PMID: 23337970 Review.
-
Infliximab-induced psoriasis during therapy for Crohn's disease.J Crohns Colitis. 2012 Jun;6(5):610-6. doi: 10.1016/j.crohns.2011.12.007. Epub 2012 Jan 26. J Crohns Colitis. 2012. PMID: 22398095
-
Infliximab and adalimumab-induced psoriasis in Crohn's disease: a paradoxical side effect.J Crohns Colitis. 2011 Apr;5(2):157-61. doi: 10.1016/j.crohns.2010.11.001. Epub 2010 Dec 7. J Crohns Colitis. 2011. PMID: 21453886
-
Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.BioDrugs. 2010 Dec 14;24 Suppl 1:3-14. doi: 10.2165/11586290-000000000-00000. BioDrugs. 2010. PMID: 21175228 Review.
Cited by
-
The Role of Alarmins in the Pathogenesis of Rheumatoid Arthritis, Osteoarthritis, and Psoriasis.Curr Issues Mol Biol. 2024 Apr 19;46(4):3640-3675. doi: 10.3390/cimb46040228. Curr Issues Mol Biol. 2024. PMID: 38666958 Free PMC article. Review.
-
Psoriasis paradox-infliximab-induced psoriasis in a patient with Crohn's disease: a case report and mini-review.J Int Med Res. 2023 Sep;51(9):3000605231200270. doi: 10.1177/03000605231200270. J Int Med Res. 2023. PMID: 37773730 Free PMC article.
-
An autoimmune pleiotropic SNP modulates IRF5 alternative promoter usage through ZBTB3-mediated chromatin looping.Nat Commun. 2023 Mar 3;14(1):1208. doi: 10.1038/s41467-023-36897-z. Nat Commun. 2023. PMID: 36869052 Free PMC article.
-
Metabolic Syndrome in Psoriasis Is Associated With Upregulation of CXCL16 on Monocytes and a Dysbalance in Innate Lymphoid Cells.Front Immunol. 2022 Jun 17;13:916701. doi: 10.3389/fimmu.2022.916701. eCollection 2022. Front Immunol. 2022. PMID: 35784287 Free PMC article.
-
Comorbidity in Adult Psoriasis: Considerations for the Clinician.Psoriasis (Auckl). 2022 Jun 10;12:139-150. doi: 10.2147/PTT.S328572. eCollection 2022. Psoriasis (Auckl). 2022. PMID: 35712227 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical